Gene · 5608
Papers2,492
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 2,492
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Potential Biomarkers and Endometrial Immune Microenvironment in Recurrent Implantation Failure. | Biomolecules | 2023 | 36979341 | PubTator, text mining | PubMed |
| Establishment of a new prognostic risk model of MAPK pathway-related molecules in kidney renal clear cell carcinoma based on genomes and transcriptomes analysis. | Front Oncol | 2023 | 36969076 | PubTator, text mining | PubMed |
| Effects of Vegetal Extracts and Metabolites against Oxidative Stress and Associated Diseases: Studies in Caenorhabditis elegans. | ACS Omega | 2023 | 36936291 | PubTator, text mining | PubMed |
| The cellular and KSHV A-to-I RNA editome in primary effusion lymphoma and its role in the viral lifecycle. | Nat Commun | 2023 | 36914661 | PubTator, text mining | PubMed |
| Regulation of MAPK Signaling Pathways by the Large HERC Ubiquitin Ligases. | Int J Mol Sci | 2023 | 36902336 | PubTator, text mining | PubMed |
| Molecular basis of skin photoaging and therapeutic interventions by plant-derived natural product ingredients: A comprehensive review. | Heliyon | 2023 | 36895391 | PubTator, text mining | PubMed |
| Loss of TTC17 promotes breast cancer metastasis through RAP1/CDC42 signaling and sensitizes it to rapamycin and paclitaxel. | Cell Biosci | 2023 | 36895029 | PubTator, text mining | PubMed |
| Multiomics analysis revealed the mechanisms related to the enhancement of proliferation, metastasis and EGFR-TKI resistance in EGFR-mutant LUAD with ARID1A deficiency. | Cell Commun Signal | 2023 | 36869329 | PubTator, text mining | PubMed |
| Network pharmacology-based analysis of Resinacein S against non-alcoholic fatty liver disease by modulating lipid metabolism. | Front Nutr | 2023 | 36866057 | PubTator, text mining | PubMed |
| Mechanism of action of non-coding RNAs and traditional Chinese medicine in myocardial fibrosis: Focus on the TGF-β/Smad signaling pathway. | Front Pharmacol | 2023 | 36843918 | PubTator, text mining | PubMed |
| A Receptor Tyrosine Kinase Inhibitor Sensitivity Prediction Model Identifies AXL Dependency in Leukemia. | Int J Mol Sci | 2023 | 36835239 | PubTator, text mining | PubMed |
| The Relationship between Iron and LRRK2 in a 6-OHDA-Induced Parkinson's Disease Model. | Int J Mol Sci | 2023 | 36835121 | PubTator, text mining | PubMed |
| nWASP Inhibition Increases Wound Healing via TrKb/PLCγ Signalling. | Biomolecules | 2023 | 36830748 | PubTator, text mining | PubMed |
| Transcriptomic Responses to Polymyxin B and Analogues in Human Kidney Tubular Cells. | Antibiotics (Basel) | 2023 | 36830325 | PubTator, text mining | PubMed |
| Understanding the function of the GABAergic system and its potential role in rheumatoid arthritis. | Front Immunol | 2023 | 36825000 | PubTator, text mining | PubMed |
Comprehensive Kinase Activity Profiling Revealed the Kinase Activity Patterns Associated with the Effects of EGFR Tyrosine Kinase Inhibitor Therapy in Advanced Non-Small-Cell Lung Cancer Patients with Sensitizing EGFR Mutations. | Proteomes | 2023 | 36810562 | PubTator, text mining | PubMed |
| Can biomarkers identified from the uterine fluid transcriptome be used to establish a noninvasive endometrial receptivity prediction tool? A proof-of-concept study. | Reprod Biol Endocrinol | 2023 | 36805767 | PubTator, text mining | PubMed |
| Modeling Ewing Sarcoma Lung Metastasis. | Curr Protoc | 2023 | 36799651 | PubTator, text mining | PubMed |
| Signaling pathways in rheumatoid arthritis: implications for targeted therapy. | Signal Transduct Target Ther | 2023 | 36797236 | PubTator, text mining | PubMed |
| Coadaptation fostered by the SLIT2-ROBO1 axis facilitates liver metastasis of pancreatic ductal adenocarcinoma. | Nat Commun | 2023 | 36792623 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5608/papers?page=10